Strata Critical Medical, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $197.1M | $146.8M | $225.2M | $146.1M | — |
| Cost of revenue | $156.0M | $117.2M | $183.1M | $123.8M | — |
| Gross profit | $41.1M | $29.6M | — | — | — |
| Selling, general & administrative | $60.9M | $50.9M | — | — | — |
| Operating expenses | $63.5M | $52.1M | $33.2M | $36.6M | — |
| Operating income | -$22.4M | -$22.5M | -$68.1M | -$53.5M | — |
| Pretax income | -$20.1M | -$16.2M | -$57.5M | -$28.0M | — |
| Income tax expense | $0 | $0 | -$1.5M | -$772,000 | — |
| Net income | $41.3M | -$27.3M | -$56.1M | -$27.3M | — |
| Balance Sheet | |||||
| Cash and equivalents | $31.0M | $18.4M | $27.9M | $41.3M | $2.6M |
| Current assets | $126.2M | $160.7M | $206.3M | $218.1M | $294.9M |
| Total assets | $325.5M | $256.7M | $294.9M | $325.0M | $335.9M |
| Current liabilities | $19.8M | $22.7M | $35.5M | $26.6M | $12.8M |
| Total liabilities | $46.4M | $34.7M | $60.6M | $50.5M | $44.5M |
| Stockholders' equity | $279.1M | $221.9M | $234.3M | $274.5M | $291.4M |
| Cash Flow Statement | |||||
| Cash from operations | -$48.9M | -$2.5M | -$32.3M | -$37.1M | — |
| Depreciation and amortization | $8.2M | $6.0M | $7.1M | $5.7M | — |
| Stock-based compensation | $17.8M | $19.9M | $12.5M | $8.3M | — |
| Capital expenditure | $9.6M | $30.9M | $2.1M | $730,000 | — |
| Free cash flow | -$58.5M | -$33.4M | -$34.5M | -$37.9M | — |
| Share repurchases | $0 | $244,000 | $0 | — | — |
| Impairments | $0 | $5.8M | $20.8M | — | — |
Shares outstanding 86.5M · Free float 46.2%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.